{
    "2018-06-04": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Eli Lilly's Olumiant Gets FDA Nod for Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Olumiant",
                        "FDA",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Merck's (MRK) Keytruda Lung Cancer Data in Focus at ASCO",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "Lung Cancer",
                        "ASCO"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Eli Lilly's Olumiant Gets FDA Nod for Rheumatoid Arthritis",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Olumiant",
                        "FDA",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early",
                "features": {
                    "keywords": [
                        "FDA",
                        "LLY/INCY",
                        "RA Drug",
                        "JAZZ",
                        "SLS",
                        "Study Stopped Early"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}